Article info
Therapeutics/Prevention
Systematic review
Updated review identifies no adverse impact on mother or offspring during the perinatal period of aspirin use for prevention of preeclampsia
- Correspondence to : Professor Paul Leeson, Oxford Cardiovascular Clinical Research Facility, John Radcliffe Hospital, Oxford OX3 9DU, UK; paul.leeson{at}cardiov.ox.ac.uk
Citation
Updated review identifies no adverse impact on mother or offspring during the perinatal period of aspirin use for prevention of preeclampsia
Publication history
- First published September 19, 2014.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions